MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./280/0.1/20.09.24 Stock

Warrant

DE000ME9GR48

Real-time Bid/Ask 05:02:53 2024-05-21 am EDT
0.096 EUR / 0.176 EUR +28.30% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./280/0.1/20.09.24
Current month-49.04%
1 month-49.52%
Date Price Change
24-05-20 0.106 -4.50%
24-05-17 0.111 -10.48%
24-05-16 0.124 -3.13%
24-05-15 0.128 +7.56%
24-05-14 0.119 -4.80%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 12:41 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME9GR4
ISINDE000ME9GR48
Date issued 2024-03-01
Strike 280 $
Maturity 2024-09-20 (123 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.43
Lowest since issue 0.089
Delta0.11x
Omega 17.88
Premium18.7x
Gearing161.7x
Moneyness 0.8469
Difference Strike 42.87 $
Difference Strike %+15.31%
Spread 0.08
Spread %45.71%
Theoretical value 0.1350
Implied Volatility 21.06 %
Total Loss Probability 91.02 %
Intrinsic value 0.000000
Present value 0.1350
Break even 281.47 €
Theta-0.02x
Vega0.02x
Rho0.01x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
237.1 USD
Average target price
279 USD
Spread / Average Target
+17.66%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW